---
type: "NewsArticle"
title: "Short black cardamom trial reports attention-test gains, with industry funding"
description: "A 14-day trial randomized 96 adults to black cardamom extract, caffeine, their combination or placebo; 85 entered the final analysis. Reported test gains need independent replication and do not establish lasting cognitive benefit."
resource: "https://nootropikler.com/news/black-cardamom-extract-short-attention-trial"
tags: ["research", "cognition"]
timestamp: 2026-10-05T20:48:23Z
language: "en"
---

# Short black cardamom trial reports attention-test gains, with industry funding

A 14-day trial randomized 96 adults to black cardamom extract, caffeine, their combination or placebo; 85 entered the final analysis. Reported test gains need independent replication and do not establish lasting cognitive benefit.

Author: Nootropik News Editorial Team
Published: 2026-10-05T20:48:23Z
Update: 2026-10-05T20:48:23Z
News/source date: 2026-09-29
Production: AI-assisted sourced summary and translation; no independent medical expert review is claimed.

## Study design

The double-blind trial assigned healthy working professionals to placebo, 250 mg MA2-24 aqueous black cardamom extract, 200 mg caffeine, or both. Cognitive tests were repeated on days 1, 7 and 14 at 1, 3, 5 and 8 hours after dosing. Of 96 randomized participants, 85 were analyzed after 11 discontinued.

## Findings

The authors reported improvements in attention, processing speed, cognitive flexibility and executive-function tests compared with placebo. Patterns varied by task, day and assessment time; the combination retained effects at some later measurements. These laboratory comparisons do not demonstrate broad, sustained improvements in everyday functioning or superiority over caffeine on every outcome.

## Limitations and disclosures

The short trial tested a proprietary extract and many repeated outcomes, with attrition before analysis. Akay Natural Ingredients funded the study, and several authors were its employees; the paper says the funder had no role in study conduct or reporting. Independent, longer trials are needed. Results do not establish dementia prevention, long-term safety or benefits from ordinary culinary cardamom.

## Sources

- [Thomas et al. — Black cardamom extract clinical trial](https://doi.org/10.3389/fnins.2026.1879347) — 2026-09-29
